Shoulder Innovations, Inc. reports results for the quarter ended June 30 - Earnings Summary
Shoulder Innovations, Inc. reports results for the quarter ended June 30 - Earnings Summary
Shoulder Innovations, Inc. SI.N reported a quarterly adjusted loss of 46 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -6 cents. The mean expectation of four analysts for the quarter was for a loss of 46 cents per share. Wall Street expected results to range from -50 cents to -41 cents per share.
Revenue rose 56% to $17.18 million from a year ago; analysts expected $16.57 million.
Shoulder Innovations, Inc.'s reported EPS for the quarter was a loss of 49 cents.
The company reported a quarterly loss of $10.15 million.
Shoulder Innovations, Inc. shares had risen by 11.4% this quarter and gained 58.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 11% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Shoulder Innovations, Inc. is $23.00, about 2.5% above its last closing price of $22.43
This summary was machine generated from LSEG data August 6 at 10:42 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.46 | -0.46 | Met |
Mar. 31 2026 | -0.41 | -0.41 | Met |
Dec. 31 2025 | -0.32 | -0.38 | Missed |
Sep. 30 2025 | -0.31 | -0.64 | Missed |
Recent news on Shoulder Innovations
See all newsBrief: Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch
Shoulder Innovations, Inc. reports results for the quarter ended June 30 - Earnings Summary
Shoulder Innovations, Inc. expected to post a loss of 46 cents a share - Earnings Preview
Brief: Shoulder Innovations Reports First Quarter 2026 Financial Results And Raises Full Year Outlook
Shoulder Innovations beats Q1 revenue estimates, lifts 2026 revenue forecast